Under construction – not a live service
Sign in
Taking people in TürkiyeNo phase

The Effectiveness of Transcutaneous Sacral Neuromodulation Techniques-Magnetic Stimulation and Electrical Stimulation-on Detrusor Overactivity in Patients With Spinal Cord Injury

Key facts

Who runs it
Ankara City Hospital Bilkent
Where
Ankara, TürkiyeSee the site
Trial code
Status
Recruiting
People taking part
40 people, planned
Started
26 Mar 2025
Planned end
26 Sept 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transcutaneous Sacral Electrical Stimulation
  • Transcutaneous sacral magnetic stimulation
Record updated
11 May 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • 18-65 years old Traumatic and non-traumatic suprasacral SCI; Detrusor overactivity confirmed by urodynamics (spontaneous and/or provocative detrusor contraction during the filling phase will be accepted as detrusor overactivity) Patients who have been receiving anticholinergic and/or sympathomimetic treatment for the last 3 months and whose pharmacological medical treatment dose has not been changed since the last urodynamic examination will be included in the study

Who cannot take part

  • Patients with a metal implant within a 10 cm radius of the area where the treatment will be applied,
  • Patients who have received botox injection to the bladder in the last 6 months,
  • Patients who have received any neuromodulation technique in the last 6 months,
  • Patients who have undergone surgical procedure for neurogenic bladder,
  • Patients with a cardiac pacemaker,
  • Patients diagnosed with epilepsy,
  • Patients with another neurological disease that may affect neurogenic bladder (Parkinson's, polyneuropathy, neurodegenerative disease, cerebrovascular disease, etc.)
  • Patients with acute urinary tract infection,
  • Patients diagnosed with bladder outlet obstruction (urethral stricture, benign prostatic hyperplasia, etc.) will not be included in the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in Türkiye

  • Ankara Bilkent City HospitalAnkara, TürkiyeContact: Zeynep YAKISIRTaking people

About the trial

What the trial wants to find out

The goal of this prospective, randomized clinical trial is to compare the efficacy and safety of transcutaneous sacral magnetic stimulation versus sacral electrical stimulation for detrusor overactivity in 40 male and female patients aged 18-65 with suprasacral Spinal Cord Injury (SCI) whose DOA is confirmed by urodynamics and is refractory to anticholinergic medication. The main question(s) aims to answer :

Read full original descriptionShow less

Is there a difference between SMS and SES in their effect on objective urodynamic parameters, such as maximum detrusor pressure during filling and bladder compliance? Is there a difference between SMS and SES in reducing the frequency of incontinence episodes and improving the Neurogenic Bladder Dysfunction Score? Researchers will compare Sacral Magnetic Stimulation and Sacral Electrical Stimulation to see if there are differences in their effects on urodynamic measures, clinical symptoms, and patient satisfaction/discomfort.

Participants will:

Be randomly assigned to one of two intervention groups: Sacral Magnetic Stimulation or Sacral Electrical Stimulation.

Receive 20 sessions of the assigned transcutaneous sacral stimulation technique (5 times a week for 20 minutes per session).

Undergo a series of evaluations before and after the 20 treatment sessions, including:

Urodynamic assessment (cystometry + EMG). Clinical assessments (3-day bladder diary, Neurogenic Bladder Dysfunction Score, Neurogenic Bowel Dysfunction Score, Spinal Cord Independence Measure - SCIM).

Patient-reported outcomes (Treatment Satisfaction Level - Likert Scale, Treatment Discomfort Level - Visual Analog Scale)

The 2 groups in the trial

  • Transcutaneous sacral electrical stimulationExisting treatment, for comparison

    Suprasacral spinal cord injury patients receiving transcutaneous sacral electrical stimulation

  • Transcutaneous sacral magnetic stimulationExisting treatment, for comparison

    Suprasacral spinal cord injury patients receiving transcutaneous sacral magnetic stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Fit questions
Built from NCT07578532, who can take part
Record updated
11 May 2026